1. Home
  2. PAX vs ANIP Comparison

PAX vs ANIP Comparison

Compare PAX & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patria Investments Limited

PAX

Patria Investments Limited

HOLD

Current Price

$9.54

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

SELL

Current Price

$74.52

Market Cap

1.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PAX
ANIP
Founded
1988
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2020
1999

Fundamental Metrics

Financial Performance
Metric
PAX
ANIP
Price
$9.54
$74.52
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$14.83
★ $105.78
AVG Volume (30 Days)
★ 1.5M
314.1K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 6.66%
N/A
EPS Growth
N/A
★ 419.23
EPS
N/A
★ 3.86
Revenue
N/A
★ $206,547,000.00
Revenue This Year
$13.22
$24.85
Revenue Next Year
$9.41
$10.76
P/E Ratio
$25.65
★ $18.56
Revenue Growth
N/A
★ 2.47
52 Week Low
$9.03
$69.58
52 Week High
$17.80
$95.45

Technical Indicators

Market Signals
Indicator
PAX
ANIP
Relative Strength Index (RSI) 38.96 46.82
Support Level N/A $69.93
Resistance Level $11.74 $74.29
Average True Range (ATR) 0.40 1.83
MACD -0.21 0.00
Stochastic Oscillator 23.40 38.27

Price Performance

Historical Comparison
PAX
ANIP

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: